These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15730113)

  • 1. Community pharmacy Target Intervention Program to improve aspirin use in persons with diabetes.
    Haggerty SA; Cerulli J; Zeolla MM; Cottrell JS; Weck MB; Faragon JJ
    J Am Pharm Assoc (2003); 2005; 45(1):17-22. PubMed ID: 15730113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community pharmacist-led intervention to identify persons with diabetes not on statin therapy.
    Drake ES; Harris DK; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S125-S130. PubMed ID: 30006183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An electronic tool to aid community pharmacists in optimizing care for persons with diabetes.
    Williams SP; Nunemacher C; Holland C; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2019; 59(4S):S136-S140.e4. PubMed ID: 31248846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of pharmacist intervention on prescribing of angiotensin-converting-enzyme inhibitors, angiotensin II-receptor blockers, and aspirin for diabetic patients.
    LaMarr B; Valdez C; Driscoll K; Ryan M
    Am J Health Syst Pharm; 2010 Feb; 67(4):290-4. PubMed ID: 20133534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving aspirin prophylaxis in a primary care diabetic population.
    Faragon JJ; Waite NM; Hobson EH; Seoldo N; VanAmburgh JA; Migden H
    Pharmacotherapy; 2003 Jan; 23(1):73-9. PubMed ID: 12523462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacist-to-prescriber intervention to close therapeutic gaps for statin use in patients with diabetes: A randomized controlled trial.
    Renner HM; Hollar A; Stolpe SF; Marciniak MW
    J Am Pharm Assoc (2003); 2017; 57(3S):S236-S242.e1. PubMed ID: 28506378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extent of services provided by pharmacists in the Iowa Medicaid Pharmaceutical Case Management program.
    Carter BL; Chrischilles EA; Scholz D; Hayase N; Bell N
    J Am Pharm Assoc (Wash); 2003; 43(1):24-33. PubMed ID: 12585748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Know your diabetes risk project: Student pharmacists educating adults about diabetes risk in a community pharmacy setting.
    Letassy N; Dennis V; Lyons TJ; Harrison D; Burton M; Kirkpatrick A
    J Am Pharm Assoc (2003); 2010 Mar-Apr 1; 50(2):188-94. PubMed ID: 20199961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-directed intervention versus clinician reminders alone to improve aspirin use in diabetes: a cluster randomized trial.
    Persell SD; Denecke-Dattalo TA; Dunham DP; Baker DW
    Jt Comm J Qual Patient Saf; 2008 Feb; 34(2):98-105. PubMed ID: 18351194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Asheville Project: short-term outcomes of a community pharmacy diabetes care program.
    Cranor CW; Christensen DB
    J Am Pharm Assoc (Wash); 2003; 43(2):149-59. PubMed ID: 12688433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Columbus Air Force Base medication profile intervention practice innovation.
    Guill JV; Griffin LA; Goodwin TD
    J Am Pharm Assoc (2003); 2008; 48(5):654-8. PubMed ID: 18826905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing an advanced community pharmacy practice experience through use of a student pharmacist manual.
    Patel J
    J Am Pharm Assoc (2003); 2008; 48(1):64-70. PubMed ID: 18192133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of simulated patients to assess diabetes and asthma counseling practices among community pharmacists in Qatar.
    Paravattil B; Kheir N; Yousif A
    Int J Clin Pharm; 2017 Aug; 39(4):759-768. PubMed ID: 28466396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of an over-the-counter intervention follow-up program in community pharmacies.
    Bosse N; Machado M; Mistry A
    J Am Pharm Assoc (2003); 2012; 52(4):535-40, 5 p following 540. PubMed ID: 22825235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient counseling provided in community pharmacies: effects of state regulation, pharmacist age, and busyness.
    Svarstad BL; Bultman DC; Mount JK
    J Am Pharm Assoc (2003); 2004; 44(1):22-9. PubMed ID: 14965149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of a community pharmacy-based influenza vaccination program.
    Ernst ME; Chalstrom CV; Currie JD; Sorofman B
    J Am Pharm Assoc (Wash); 1997; NS37(5):570-80. PubMed ID: 9479410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of aspirin use in patients with diabetes receiving care in community health.
    Fosmire Rundgren EW; Anderson SL; Marrs JC
    Ann Pharmacother; 2015 Feb; 49(2):170-7. PubMed ID: 25288823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extent of services provided by pharmacists in the iowa medicaid pharmaceutical case management program.
    Carter BL; Chrischilles EA; Scholz D; Hayase N; Bell N
    J Am Pharm Assoc (Wash); 2003 Jan; 43(1):24-33. PubMed ID: 23945801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physician acceptance of pharmacotherapy recommendations made by pharmacy students in a rural pharmacy-based diabetes care and education clinic.
    McCollum M; Nuffer W; Ellis SL; Turner CJ
    Am J Pharm Educ; 2009 Apr; 73(2):24. PubMed ID: 19513162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.